Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The antigenic potency of non-infectious poliomyelitis virus as determined by its liberating effect on active virus neutralized by immune serum.

Literature DB >> 13233455

The antigenic potency of non-infectious poliomyelitis virus as determined by its liberating effect on active virus neutralized by immune serum.

Abstract

The activation of poliomyelitis virus from a "neutral" virus-antibody mixture by the addition of non-infectious virus is described. The phenomenon was demonstrated in tissue cultures using both Petri dishes and roller tubes. The reaction was found to be type-specific and a relationship between antigen dilution and number of plaques counted was established. The relative potency of vaccine preparations determined in this system was found to be comparable to their relative potency in respect to protection-inducing activity in mice.

Entities: Disease Species

Keywords: ANTIGENS AND ANTIBODIES; POLIOMYELITIS VIRUS

Mesh：

Substances：

Year: 1955 PMID： 13233455 PMCID： PMC2136467 DOI： 10.1084/jem.101.3.331

Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307

8 in total

1. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.

Authors: J E SALK; P L BAZELEY; B L BENNETT; U KRECH; L J LEWIS; E N WARD; J S YOUNGNER
Journal: Am J Public Health Nations Health Date: 1954-08

2. Preparation and standardization of antiserums prepared with the three known types to poliomyelitis viruses.

Authors: H A WENNER; C A MILLER; P KAMITSUKA; J C WILSON
Journal: Am J Hyg Date: 1954-03

3. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines.

Authors: J E SALK; U KRECH; J S YOUNGNER; B L BENNETT; L J LEWIS; P L BAZELEY
Journal: Am J Public Health Nations Health Date: 1954-05

4. Antibody response of chimpanzees and human beings to formalin-inactivated trivalent poliomyelitis vaccine.

Authors: H A HOWE
Journal: Am J Hyg Date: 1952-11

5. Immunization of mice with inactivated type 2 poliomyelitis virus against types 2 and 3 viruses.

Authors: J CASALS; P K OLITSKY; L V BROWN
Journal: Proc Soc Exp Biol Med Date: 1952 Aug-Sep

6. The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses.

Authors: J E SALK; L J LEWIS; J S YOUNGNER; B L BENNETT
Journal: Am J Hyg Date: 1951-09

7. Immunization of cotton rats with inactivated Lansing poliomyelitis virus. I. Inactivation by chemical agents.

Authors: C E SCHWERDT; G W A DICK; R M HERRIOTT; H A HOWE
Journal: Am J Hyg Date: 1951-03

8. Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors: R DULBECCO; M VOGT
Journal: J Exp Med Date: 1954-02 Impact factor: 14.307

8 in total

6 in total

6. Detection of respiratory syncytial virus in nasopharyngeal secretions by inhibition of enzyme-linked immunosorbent assay.

Authors: A Hornsleth; E Brenøe; B Friis; F U Knudsen; P Uldall
Journal: J Clin Microbiol Date: 1981-11 Impact factor: 5.948

6 in total

The antigenic potency of non-infectious poliomyelitis virus as determined by its liberating effect on active virus neutralized by immune serum.

1. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.

2. Preparation and standardization of antiserums prepared with the three known types to poliomyelitis viruses.

3. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines.

4. Antibody response of chimpanzees and human beings to formalin-inactivated trivalent poliomyelitis vaccine.

5. Immunization of mice with inactivated type 2 poliomyelitis virus against types 2 and 3 viruses.

6. The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses.

7. Immunization of cotton rats with inactivated Lansing poliomyelitis virus. I. Inactivation by chemical agents.

8. Plaque formation and isolation of pure lines with poliomyelitis viruses.

1. Potency of poliomyelitis vaccines estimated by an antibody combining test.

2. [Determination of the antigenic value of poliomyelitis vaccine].

3. Neutralizing-antibody-combining (NAC) test for measuring antigenic potency of poliomyelitis vaccine.

4. The determination of antigenic potency of poliomyelitis vaccine by measuring its antibody-combining capacity.

5. [The kinetic reaction of sero-neutralization of poliomyelitis virus].

6. Detection of respiratory syncytial virus in nasopharyngeal secretions by inhibition of enzyme-linked immunosorbent assay.